Sight Change In Cash from 2010 to 2025

SGHT Stock  USD 2.32  0.14  5.69%   
Sight Sciences Change In Cash yearly trend continues to be comparatively stable with very little volatility. Change In Cash is likely to outpace its year average in 2025. From the period from 2010 to 2025, Sight Sciences Change In Cash quarterly data regression had mean square error of 3766 T and mean deviation of  31,445,069. View All Fundamentals
 
Change In Cash  
First Reported
2010-12-31
Previous Quarter
-42.2 M
Current Value
-40.1 M
Quarterly Volatility
59.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Sight Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sight Sciences' main balance sheet or income statement drivers, such as Tax Provision of 74.8 K, Interest Income of 0.0 or Depreciation And Amortization of 858.2 K, as well as many indicators such as Price To Sales Ratio of 3.38, Dividend Yield of 0.0 or PTB Ratio of 1.97. Sight financial statements analysis is a perfect complement when working with Sight Sciences Valuation or Volatility modules.
  
Check out the analysis of Sight Sciences Correlation against competitors.
For more information on how to buy Sight Stock please use our How to Invest in Sight Sciences guide.

Latest Sight Sciences' Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Sight Sciences over the last few years. It is Sight Sciences' Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Sight Sciences' overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Very volatile
   Change In Cash   
17.0M40.3M199.2M-75.7M-46.9M-42.2M-40.1M100%
       Timeline  

Sight Change In Cash Regression Statistics

Arithmetic Mean1,628,150
Coefficient Of Variation3,648
Mean Deviation31,445,069
Median(2,842,000)
Standard Deviation59,398,686
Sample Variance3528.2T
Range274.9M
R-Value(0.06)
Mean Square Error3766T
R-Squared0
Significance0.82
Slope(765,650)
Total Sum of Squares52923.1T

Sight Change In Cash History

2025-40.1 M
2024-42.2 M
2023-46.9 M
2022-75.7 M
2021199.2 M
202040.3 M
201917 M

About Sight Sciences Financial Statements

Sight Sciences shareholders use historical fundamental indicators, such as Change In Cash, to determine how well the company is positioned to perform in the future. Although Sight Sciences investors may analyze each financial statement separately, they are all interrelated. The changes in Sight Sciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Sight Sciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Change In Cash-42.2 M-40.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Sight Stock Analysis

When running Sight Sciences' price analysis, check to measure Sight Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sight Sciences is operating at the current time. Most of Sight Sciences' value examination focuses on studying past and present price action to predict the probability of Sight Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sight Sciences' price. Additionally, you may evaluate how the addition of Sight Sciences to your portfolios can decrease your overall portfolio volatility.

Trending Assets

VREX
Varex Imaging Corp
13.07  0.01  0.08 
CVRX
CVRx Inc
13.28  0.12  0.91 
NPCE
Neuropace
13.62  0.10  0.74 
TCMD
Tactile Systems Tech
14.14  -0.76  -5.1 
FNA
Paragon 28
13.02  -0.02  -0.15 
RPID
Rapid Micro Biosystems
2.50  -0.3  -10.71 
SIBN
Si Bone
18.41  0.94  5.38 
AVNS
Avanos Medical
15.63  0.18  1.17 
LUNG
Pulmonx Corp
8.57  -0.35  -3.92 
KIDS
Orthopediatrics Corp
22.74  -0.75  -3.19 
ANIK
Anika Therapeutics
17.79  0.36  2.07 
OFIX
Orthofix Medical
17.05  -0.9  -5.01 
CNMD
CONMED
61.92  -0.05  -0.08 
AORT
Artivion
25.11  -2.74  -9.84 
NUVA
NuVasive
0.00  0.00  0.00 
News Freq…Investor S…